468 related articles for article (PubMed ID: 24022624)
21. Ratio of apoB/LDL: a potential clinical index for vascular cognitive impairment.
Qian C; Tan F
BMC Neurol; 2016 Nov; 16(1):243. PubMed ID: 27887584
[TBL] [Abstract][Full Text] [Related]
22. Vascular dementia may be the most common form of dementia in the elderly.
Román GC
J Neurol Sci; 2002 Nov; 203-204():7-10. PubMed ID: 12417349
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotection in vascular dementia.
Martínez-Vila E; Murie-Fernández M; Gállego Pérez-Larraya J; Irimia P
Cerebrovasc Dis; 2006; 21 Suppl 2():106-17. PubMed ID: 16651821
[TBL] [Abstract][Full Text] [Related]
24. Vascular cognitive impairment and vascular dementia.
Rockwood K
J Neurol Sci; 2002 Nov; 203-204():23-7. PubMed ID: 12417352
[TBL] [Abstract][Full Text] [Related]
25. Neuropsychological performance in patients with subcortical stroke.
Andrade SP; Brucki SM; Bueno OF; Siqueira Neto JI
Arq Neuropsiquiatr; 2012 May; 70(5):341-7. PubMed ID: 22358308
[TBL] [Abstract][Full Text] [Related]
26. Treatment options and considerations for hypertensive patients to prevent dementia.
Hernandorena I; Duron E; Vidal JS; Hanon O
Expert Opin Pharmacother; 2017 Jul; 18(10):989-1000. PubMed ID: 28532183
[TBL] [Abstract][Full Text] [Related]
27. Dementia, stroke, and vascular risk factors; a review.
Sahathevan R; Brodtmann A; Donnan GA
Int J Stroke; 2012 Jan; 7(1):61-73. PubMed ID: 22188853
[TBL] [Abstract][Full Text] [Related]
28. Vascular cognitive deterioration and stroke.
Erkinjuntti T
Cerebrovasc Dis; 2007; 24 Suppl 1():189-94. PubMed ID: 17971655
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
[TBL] [Abstract][Full Text] [Related]
30. Vascular cognitive impairment and dementia expenditures: 7-year inpatient cost description in community dwellers.
Ramos-Estebanez C; Moral-Arce I; Rojo F; Gonzalez-Macias J; Hernandez JL
Postgrad Med; 2012 Sep; 124(5):91-100. PubMed ID: 23095429
[TBL] [Abstract][Full Text] [Related]
31. Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease.
Ramos-Estebanez C; Moral-Arce I; Gonzalez-Mandly A; Dhagubatti V; Gonzalez-Macias J; Munoz R; Hernadez-Hernandez JL
Age Ageing; 2011 Mar; 40(2):175-80. PubMed ID: 21239411
[TBL] [Abstract][Full Text] [Related]
32. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia.
Duncombe J; Kitamura A; Hase Y; Ihara M; Kalaria RN; Horsburgh K
Clin Sci (Lond); 2017 Oct; 131(19):2451-2468. PubMed ID: 28963120
[TBL] [Abstract][Full Text] [Related]
33. Pharmacotherapy for Vascular Cognitive Impairment.
Farooq MU; Min J; Goshgarian C; Gorelick PB
CNS Drugs; 2017 Sep; 31(9):759-776. PubMed ID: 28786085
[TBL] [Abstract][Full Text] [Related]
34. A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD.
Choi DH; Lee J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165383
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic issues in vascular dementia: studies, designs and approaches.
Black SE
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S125-30. PubMed ID: 17474183
[TBL] [Abstract][Full Text] [Related]
36. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?
Desmond DW
J Neurol Sci; 2004 Nov; 226(1-2):3-7. PubMed ID: 15537510
[TBL] [Abstract][Full Text] [Related]
37. [Cognitive decline and hypertension].
Rigaud AS; Traykov L; Hanon O; Seux ML; Latour F; Lenoir H; Olde-Rikkert M; Forette F
Arch Mal Coeur Vaiss; 2003 Jan; 96(1):47-51. PubMed ID: 12613149
[TBL] [Abstract][Full Text] [Related]
38. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
[TBL] [Abstract][Full Text] [Related]
39. Vascular cognitive impairment.
Farooq MU; Gorelick PB
Curr Atheroscler Rep; 2013 Jun; 15(6):330. PubMed ID: 23612956
[TBL] [Abstract][Full Text] [Related]
40. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review.
Torres-Simón L; Doval S; Nebreda A; Llinas SJ; Marsh EB; Maestú F
Neuroimage Clin; 2022; 35():103040. PubMed ID: 35653914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
